Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Navari

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The American Journal of Physiology|April 11, 1978
Responses of cerebral arteries and arterioles to acute hypotension and hypertensionH A Kontos, E P Wei, R M Navari, et al.
The American Journal of Physiology|May 11, 1978
Role of tissue hypoxia in local regulation of cerebral microcirculationH A Kontos, E P Wei, A J Raper, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1997
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesisE A Perez, R M Navari, H G Kaplan, et al.
Metabolism: Clinical and Experimental|March 1, 1993
Protein turnover in advanced lung cancer patientsE W Richards, C L Long, K M Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapyR J Gralla, R M Navari, P J Hesketh, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 1992
Glucose metabolism in advanced lung cancer patientsE W Richards, C L Long, K M Nelson, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
The American Journal of Physiology|April 11, 1981
Mechanism of cerebral arteriolar abnormalities after acute hypertensionH A Kontos, E P Wei, W D Dietrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placeboR M Navari, S Madajewicz, N Anderson, et al.
Blood Cancer Journal|July 26, 2012
Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivoT Kiziltepe, J D Ashley, J F Stefanick, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The American Journal of Physiology|April 11, 1978
Responses of cerebral arteries and arterioles to acute hypotension and hypertensionH A Kontos, E P Wei, R M Navari, et al.
The American Journal of Physiology|May 11, 1978
Role of tissue hypoxia in local regulation of cerebral microcirculationH A Kontos, E P Wei, A J Raper, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1997
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesisE A Perez, R M Navari, H G Kaplan, et al.
Metabolism: Clinical and Experimental|March 1, 1993
Protein turnover in advanced lung cancer patientsE W Richards, C L Long, K M Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapyR J Gralla, R M Navari, P J Hesketh, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 1992
Glucose metabolism in advanced lung cancer patientsE W Richards, C L Long, K M Nelson, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
The American Journal of Physiology|April 11, 1981
Mechanism of cerebral arteriolar abnormalities after acute hypertensionH A Kontos, E P Wei, W D Dietrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placeboR M Navari, S Madajewicz, N Anderson, et al.
Blood Cancer Journal|July 26, 2012
Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivoT Kiziltepe, J D Ashley, J F Stefanick, et al.
Pageof 4